Antihemophilic Factor

In the US, Antihemophilic Factor (antihemophilic factor systemic) is a member of the drug class miscellaneous coagulation modifiers and is used to treat Hemophilia A.

US matches:

• Antihemophilic Factor (Human)


• Antihemophilic Factor (Recombinant)


• Antihemophilic Factor (Recombinant) (Plasma/Albumin Free) (Advate)


• Antihemophilic Factor (Recombinant) (Plasma/Albumin-Free)


• Antihemophilic Factor (Recombinant) (Plasma/Albumin-Free) (Xyntha)


• Antihemophilic Factor (Recombinant) Plasma/Albumin Free


• Antihemophilic Factor/von Willebrand Factor


• Antihemophilic Factor/von Willebrand Factor (Human)


• Antihemophilic factor human


• Antihemophilic factor recombinant


• Antihemophilic factor-von Willebrand factor complex


• Antihemophilic factor Intravenous, Injection


• Antihemophilic factor viii and von willebrand factor complex Intravenous


• Antihemophilic Factor


• Antihemophilic Factor/von Willebrand Factor Complex


• Antihemophilic Factor/von Willebrand Factor Complex (Human)

Ingredient matches for Antihemophilic Factor

Coagulation Factor VIII , Human (rDNA)

Coagulation Factor VIII , Human (rDNA) Octocog Alfa (a derivative of Coagulation Factor VIII , Human (rDNA)) is reported as an ingredient of Antihemophilic Factor in the following countries:

• Israel

International Drug Name Search